Comprehensive Genomic Profiling Combined With Real Life Data of "The German-Registry of Incidental Gallbladder Carcinoma"

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-10-11

Study Completion Date

2099-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Multicenter German- Registry of Incidental Gallbladder Carcinoma combining clinical real-world data and comprehensive genomic profiling. The registry collects medical data from clinical observation and molecular data derived from archival tumor tissue samples but does not define any medical intervention nor does it evaluate the efficacy or safety of the treatment decision made by the investigator.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

NGS in Gallbladder Cancer and Response to Treatment

NCT05404347

Gallbladder Cancer

RECRUITING

Prevalence of BRCA in Patients With Ovarian Cancer

NCT02222883

BRCA Status Ovarian Cancer

COMPLETED

The Registry of Genetic Alterations of Taiwan Biliary Tract Cancer

NCT05036486

Biliary Tract Cancer (BTC)

ACTIVE_NOT_RECRUITING

Treatment Guided by Comprehensive Genome and Transcriptome Analysis Versus Standard of Care in Advanced Rare Cancers

NCT06855134

Rare Cancer

NOT_YET_RECRUITING

Evaluation of Efficacy of Comprehensive Genomic Tumour Profiling (CGP) From Liquid and/or Tissue Biopsy in Patients With Locally Advanced and/or Metastatic Solid Cancer

NCT05032092

Locally Advanced Carcinoma Metastatic Cancer

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In the largest cohort of IGBC patients ever analysed in such a comprehensive approach

* determine the course of patients in this rare kind of cancer
* combine cGP analysis of histological tumor samples with clinical real-life data to get a comprehensive overview on IGBC patients analysed and evaluate data to identify possible further (targeted) treatment possibilities
* analyze potential risk factors associated with gallbladder carcinoma
* assess the frequency of targetable mutations in IGBC

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gallbladder Carcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Histologically confirmed diagnosis of incidental gallbladder carcinoma

* Patient ≥ 18 years old
* Patient already deceased
* Available tumor tissue (FFPE block)